Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Blanke

Showing results (1-10 of 190) with videos related to

Pageof 19
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 9, 2005
Whither irinotecan?Charles D Blanke
Practical Radiation Oncology|September 17, 2019
The Gift of Dying With ControlCharles D Blanke
Oncology (Williston Park, N.Y.)|May 17, 2002
Celecoxib with chemotherapy in colorectal cancerCharles D Blanke
Gastrointestinal Cancer Research : GCR|March 5, 2009
Perforation and Stage-II Colon Cancer: Is it Always High Risk?Charles D Blanke
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2008
Dual-antibody therapy in advanced colorectal cancer: gather ye rosebuds while ye mayCharles D Blanke
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2009
Biomarkers in GIST: partly ready for prime-time useCharles D Blanke
Journal of Oncology Practice|September 3, 2011
Commentary: clinical trials represent the best cancer care. Or do they?Charles D Blanke
JAMA|March 29, 2012
Optimal duration of adjuvant therapy for patients with resected gastrointestinal stromal tumorsCharles D Blanke
The American Journal of Bioethics : AJOB|October 25, 2023
To the EditorCharles D Blanke
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2005
Gefitinib in colorectal cancer: if wishes were horsesCharles D Blanke
Pageof 19

Showing results (1-10 of 190) with videos related to

Sort By:
Pageof 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 9, 2005
Whither irinotecan?Charles D Blanke
Practical Radiation Oncology|September 17, 2019
The Gift of Dying With ControlCharles D Blanke
Oncology (Williston Park, N.Y.)|May 17, 2002
Celecoxib with chemotherapy in colorectal cancerCharles D Blanke
Gastrointestinal Cancer Research : GCR|March 5, 2009
Perforation and Stage-II Colon Cancer: Is it Always High Risk?Charles D Blanke
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2008
Dual-antibody therapy in advanced colorectal cancer: gather ye rosebuds while ye mayCharles D Blanke
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2009
Biomarkers in GIST: partly ready for prime-time useCharles D Blanke
Journal of Oncology Practice|September 3, 2011
Commentary: clinical trials represent the best cancer care. Or do they?Charles D Blanke
JAMA|March 29, 2012
Optimal duration of adjuvant therapy for patients with resected gastrointestinal stromal tumorsCharles D Blanke
The American Journal of Bioethics : AJOB|October 25, 2023
To the EditorCharles D Blanke
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2005
Gefitinib in colorectal cancer: if wishes were horsesCharles D Blanke
Pageof 19